81 FR 2904 - Generalized System of Preferences: Possible Modifications, 2015 Review
INTERNATIONAL TRADE COMMISSION Federal Register Volume 81, Issue 11 (January 19, 2016)
Federal Register Volume 81, Issue 11 (January 19, 2016)
| Page Range | 2904-2907 | |
| FR Document | 2016-00771 |
[Federal Register Volume 81, Number 11 (Tuesday, January 19, 2016)] [Notices] [Pages 2904-2907] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-00771] ----------------------------------------------------------------------- INTERNATIONAL TRADE COMMISSION [Investigation No. 332-556] Generalized System of Preferences: Possible Modifications, 2015 Review AGENCY: United States International Trade Commission. ACTION: Notice of institution of investigation and scheduling of public hearing. ----------------------------------------------------------------------- SUMMARY: Following receipt of a request on December 30, 2015, from the United States Trade Representative (USTR), the U.S. International Trade Commission (Commission) instituted investigation No. 332-556, Generalized System of Preferences: Possible Modifications, 2015 Review, for the purpose of providing advice and information relating to the possible designation of additional articles, removal of articles, and waiver of competitive need limitations. DATES: February 1, 2016: Deadline for filing requests to appear at the public hearing. February 3, 2016: Deadline for filing pre-hearing briefs and statements. February 24, 2016: Public hearing. February 29, 2016: Deadline for filing post-hearing briefs and statements. February 29, 2016: Deadline for filing all other written submissions. April 28, 2016: Transmittal of Commission report to the United States Trade Representative. ADDRESSES: All Commission offices, including the Commission's hearing rooms, are located in the United States International Trade Commission Building, 500 E Street SW., Washington, DC. All written submissions should be addressed to the Secretary, United States International Trade Commission, 500 E Street SW., Washington, DC 20436. The public record for this investigation may be viewed on the Commission's electronic docket (EDIS) at http://www.usitc.gov/secretary/edis.htm. FOR FURTHER INFORMATION CONTACT: Information specific to this investigation may be obtained from Mahnaz Khan, Project Leader, Office of Industries (202-205-2046 or [email protected]), Jessica Pugliese, Deputy Project Leader, Office of Industries (202-205-3064 or [email protected]), or Cynthia Foreso, Technical Advisor, Office of Industries (202-205-3348 or [email protected]). For information on the legal aspects of this investigation, contact William Gearhart of the Commission's Office of the General Counsel (202-205- 3091 or [email protected]). The media should contact Margaret O'Laughlin, Office of External Relations (202-205-1819 or [email protected]). Hearing-impaired individuals may obtain information on this matter by contacting the Commission's TDD terminal at 202-205-1810. General information concerning the Commission may also be obtained by accessing its Web site (http://www.usitc.gov). Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202-205-2000. Background In his letter, the USTR requested the advice and information described below. (1) Advice concerning the probable economic effect of elimination of U.S. import duties on certain articles from all beneficiary developing countries under the GSP program. In accordance with sections 503(a)(1)(A), 503(e), and 131(a) of the Trade Act of 1974, as amended (``the 1974 Act'') (19 U.S.C. 2463(a)(1)(A), 2463(e), and 2151(a)), and pursuant to the authority of the President delegated to the USTR by sections 4(c) and 8(c) and (d) of Executive Order 11846 of March 31, 1975, as amended, and pursuant to section 332(g) of the Tariff Act of 1930 (19 U.S.C. 1332(g)), the USTR notified the Commission that the articles identified in Table A of the Annex to the USTR request letter are being considered for designation as eligible articles for purposes of the GSP program. The USTR requested that the [[Page 2905]] Commission provide its advice as to the probable economic effect on total U.S. imports, U.S. industries producing like or directly competitive articles, and on U.S. consumers of the elimination of U.S. import duties on the articles identified in Table A of the Annex to the USTR request letter for all beneficiary developing countries under the GSP program (see Table A below). (2) Advice concerning the probable economic effect of elimination of U.S. import duties on certain handbags and travel goods products for least-developed beneficiary developing countries (LDBDCs) and certain African Growth and Opportunity (AGOA) countries. In accordance with sections 503(a)(1)(B), 503(e), 506A(b)(1), and 131(a) of the 1974 Act, and pursuant to the authority of the President delegated to the USTR by sections 4(c) and 8(c) and (d) of Executive Order 11846 of March 31, 1975, as amended, and pursuant to section 332(g) of the Tariff Act of 1930, the USTR notified the Commission that certain handbags and travel goods products identified in Table A of the Annex to the USTR request letter are also being considered for designation as eligible articles for countries designated as least-developed beneficiary developing countries (LDBDCs) and for countries listed in section 107 of the African Growth and Opportunity Act (AGOA) (19 U.S.C. 3706). The USTR requested that the Commission provide its advice as to the probable economic effect on total U.S. imports, U.S. industries producing like or directly competitive articles, and on U.S. consumers of the elimination of U.S. import duties on certain handbag and travel goods products identified in Table A for LDBDCs, AGOA beneficiary developing countries, and both LDBDCs and AGOA beneficiary developing countries combined under the GSP program (see Table A below). Table A--Possible Additions to the List of Products Eligible for the GSP Eligible Products ------------------------------------------------------------------------ HTS Subheading or statistical reporting number Brief description Country(ies) ------------------------------------------------------------------------ 2204.21.20.................. Effervescent wine... Beneficiary Developing Countries. 3301.13.00.................. Essential oils of Beneficiary lemon. Developing Countries. 7202.11.50.................. Ferromanganese Beneficiary containing by Developing weight more than 4 Countries. percent of carbon. 4202.11.00; 4202.11.00.30; Certain handbags and Beneficiary 4202.11.00.90; 4202.12.40; travel goods Developing 4202.21.60; 4202.21.90; products. Countries, Less 4202.22.15; 4202.22.45; Developed 4202.31.60; 4202.32.40; Beneficiary 4202.32.80; 4202.92.15; Developing 4202.92.20; 4202.92.45; countries, and AGOA 4202.99.90; 4202.12.20.20; countries. 4202.12.20.50; 4202.12.80.30; 4202.12.80.70; 4202.22.80.50; 4202.32.95.50; 4202.32.95.60; 4202.91.00.30; 4202.91.00.90. ------------------------------------------------------------------------ (3) Advice concerning the probable economic effect of removal of certain articles from specified countries from eligibility for duty- free treatment. The USTR notified the Commission that certain articles are being considered for removal from eligibility for duty free treatment under the GSP program from specified countries. Under authority delegated by the President, pursuant to section 332(g) of the Tariff Act of 1930, with respect to articles listed in Table B of the Annex to the USTR request letter, the USTR requested that the Commission provide its advice as to the probable economic effect of the removal from eligibility for duty-free treatment under the GSP program for such articles from the specified country on total U.S. imports, U.S. industries producing like or directly competitive articles, and on U.S. consumers (see Table B below). Table B--Possible Removals From Duty-Free Status From the Specified Country for a Product on the List of Eligible Articles for the GSP ------------------------------------------------------------------------ HTS Subheading Brief description Country ------------------------------------------------------------------------ 3204.20.10.................. Fluorescent India and Indonesia. brightening agent 32. 3204.20.80.................. Other fluorescent India and Indonesia. brightening agents. 3907.60.00.................. PET resin India. (polyethylene terephthalate in primary forms). 3920.62.00.................. Nonadhesive plates, Brazil. sheets, film, foil and strip, noncellular, of polyethylene terephthalate. 3921.90.40.................. Nonadhesive plates, Brazil. sheets, film, foil and strip, flexible, nesoi, of noncellular plastics. ------------------------------------------------------------------------ (4) Advice concerning waiver of certain competitive need limitations. Under authority delegated by the President, pursuant to section 332(g) of the Tariff Act of 1930, and in accordance with section 503(d)(1)(A) of the 1974 Act, the USTR requested that the Commission provide advice on whether any industry in the United States is likely to be adversely affected by a waiver of the competitive need limitations specified in section 503(c)(2)(A) of the 1974 Act for the countries and articles specified in Table C of the attached Annex to the request letter (see Table C below). Further, in accordance with section 503(c)(2)(E) of the 1974 Act, the USTR requested that the Commission provide its advice with respect to whether like or directly competitive products were being produced in the United States on January 1, 1995. The USTR also requested that the Commission provide its advice as to the probable economic effect on total U.S. imports, as well as on consumers, of the requested waivers. With respect to the competitive need limit in section 503(c)(2(A)(i)(I) of the 1974 Act, the USTR requested that the [[Page 2906]] Commission use the dollar value limit of $170,000,000. Table C--Possible Waivers of the CNL From a Specific Country ------------------------------------------------------------------------ HTS Subheading Brief description Country ------------------------------------------------------------------------ 0804.10.60.................. Dates, fresh or Tunisia. dried, whole, without pits, packed in units weighing over 4.6 kg. 1509.10.40.................. Virgin olive oil and Tunisia. its fractions, whether or not refined, not chemically modified, weighing with the immediate container 18 kg or over. 2102.20.60.................. Single-cell micro- Brazil. organisms, dead, excluding yeasts, (but not including vaccines of heading 3002). 2202.90.90.................. Nonalcoholic Thailand. beverages, nesi, not including fruit or vegetable juices of heading 2009. 2804.29.00.................. Rare gases, other Ukraine. than argon. 4202.92.04.................. Insulated beverage Philippines. bag w/outer surface textiles, interior only flexible plastic container storing/dispensing beverage thru flexible tubing. 6911.10.37.................. Porcelain or china Indonesia. (o/than bone china) household table & kitchenware in sets in which aggregate val. of arts./U.S. note 6(b) o/$56 n/o $200. 8708.50.95.................. Parts & accessories India. of motor vehicle of 8701, nesoi, 8702 and 8704-8705, half- shafts. ------------------------------------------------------------------------ Time for reporting, HTS detail, portions of report to be classified. As requested by the USTR, the Commission will provide the requested advice and information by April 28, 2016. The USTR asked that the Commission issue, as soon as possible thereafter, a public version of the report containing only the unclassified information, with any confidential business information deleted. As requested, the Commission will provide its advice and statistics (profile of the U.S. industry and market and U.S. import and export data) and any other relevant information or advice separately and individually for each U.S. Harmonized Tariff Schedule subheading for all products subject to the request. The USTR indicated that those sections of the Commission's report and working papers that contain the Commission's advice and assessment will be classified as ``confidential.'' The USTR also stated that his office considers the Commission's report to be an inter-agency memorandum that will contain pre-decisional advice and be subject to the deliberative process privilege. Public Hearing A public hearing in connection with this investigation will be held at the U.S. International Trade Commission Building, 500 E Street SW., Washington, DC, beginning at 9:30 a.m. on February 24, 2016. Requests to appear at the public hearing should be filed with the Secretary no later than 5:15 p.m., February 1, 2016. All pre-hearing briefs and statements should be filed no later than 5:15 p.m., February 3, 2016; and all post-hearing briefs and statements should be filed no later than 5:15 p.m., February 29, 2016. All requests to appear, and pre- and post-hearing briefs and statements should be filed in accordance with the requirements of the ``written submissions'' section below. Written Submissions In lieu of or in addition to appearing at the hearing, interested parties are invited to file written submissions concerning this investigation. All written submissions should be addressed to the Secretary, and should be received not later than 5:15 p.m., February 29, 2016. All written submissions must conform with the provisions of section 201.8 of the Commission's Rules of Practice and Procedure (19 CFR 201.8). Section 201.8 and the Commission's Handbook on Filing Procedures require that interested parties file documents electronically on or before the filing deadline and submit eight (8) true paper copies by 12:00 p.m. eastern time on the next business day. In the event that confidential treatment of a document is requested, interested parties must file, at the same time as the eight paper copies, at least four (4) additional true paper copies in which the confidential information must be deleted (see the following paragraph for further information regarding confidential business information). Persons with questions regarding electronic filing should contact the Office of the Secretary, Docket Services Division (202-205-1802). Any submissions that contain confidential business information must also conform with the requirements of section 201.6 of the Commission's Rules of Practice and Procedure (19 CFR 201.6). Section 201.6 of the rules requires that the cover of the document and the individual pages be clearly marked as to whether they are the ``confidential'' or ``non- confidential'' version, and that the confidential business information is clearly identified by means of brackets. All written submissions, except for confidential business information, will be made available for inspection by interested parties. The Commission may include some or all of the confidential business information submitted in the course of this investigation in the report it sends to the USTR. Additionally, all information, including confidential business information, submitted in this investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel (a) for cybersecurity purposes or (b) in monitoring user activity on U.S. government classified networks. The Commission will not otherwise disclose any confidential business information in a manner that would reveal the operations of the firm supplying the information. [[Page 2907]] Summaries of Written Submissions The Commission intends to publish summaries of the positions of interested persons. Persons wishing to have a summary of their position included in the report should include a summary with their written submission. The summary may not exceed 500 words, should be in MSWord format or a format that can be easily converted to MSWord, and should not include any confidential business information. The summary will be published as provided if it meets these requirements and is germane to the subject matter of the investigation. The Commission will identify the name of the organization furnishing the summary and will include a link to the Commission's Electronic Document Information System (EDIS) where the full written submission can be found. By order of the Commission. Issued: January 12, 2016. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2016-00771 Filed 1-15-16; 8:45 am] BILLING CODE 7020-02-P
![2904 Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices
of the final phase of its investigation. opportunity were permitted to appear in International Trade Commission
The Commission will issue a final phase person or by counsel. Building, 500 E Street SW., Washington,
notice of scheduling, which will be The Commission made this DC. All written submissions should be
published in the Federal Register as determination pursuant to section addressed to the Secretary, United
provided in section 207.21 of the 733(a) of the Tariff Act of 1930 (19 States International Trade Commission,
Commission’s rules, upon notice from U.S.C. 1673b(a)). It completed and filed 500 E Street SW., Washington, DC
the Department of Commerce its determination in this investigation 20436. The public record for this
(‘Commerce’’) of an affirmative on August 10, 2015. The views of the investigation may be viewed on the
preliminary determination in the Commission are contained in USITC Commission’s electronic docket (EDIS)
investigation under section 733(b) of the Publication 4558 (August 2015), entitled at http://www.usitc.gov/secretary/
Act, or, if the preliminary determination Hydrofluorocarbon Blends and edis.htm.
is negative, upon notice of an Components from China: Investigation FOR FURTHER INFORMATION CONTACT:
affirmative final determination in that No. 731–TA–1279 (Preliminary). Information specific to this investigation
investigation under section 735(a) of the By order of the Commission. may be obtained from Mahnaz Khan,
Act. Parties that filed entries of Dated: August 11, 2015. Project Leader, Office of Industries
appearance in the preliminary phase of William R. Bishop, (202–205–2046 or mahnaz.khan@
the investigation need not enter a
Supervisory Hearings and Information usitc.gov), Jessica Pugliese, Deputy
separate appearance for the final phase Officer. Project Leader, Office of Industries
of the investigation. Industrial users,
EDITORIAL NOTE: This document was (202–205–3064 or jessica.pugliese@
and, if the merchandise under
received for publication by the Office of usitc.gov), or Cynthia Foreso, Technical
investigation is sold at the retail level,
the Federal Register on January 13, Advisor, Office of Industries (202–205–
representative consumer organizations
2016. 3348 or cynthia.foreso@usitc.gov). For
have the right to appear as parties in
Commission antidumping and
[FR Doc. 2016–00874 Filed 1–15–16; 8:45 am] information on the legal aspects of this
countervailing duty investigations. The BILLING CODE 7020–02–P investigation, contact William Gearhart
Secretary will prepare a public service of the Commission’s Office of the
list containing the names and addresses General Counsel (202–205–3091 or
INTERNATIONAL TRADE william.gearhart@usitc.gov). The media
of all persons, or their representatives, COMMISSION
who are parties to the investigation. should contact Margaret O’Laughlin,
[Investigation No. 332–556] Office of External Relations (202–205–
Background 1819 or margaret.olaughlin@usitc.gov).
On June 25, 2015, American HFC Generalized System of Preferences: Hearing-impaired individuals may
Coalition, and its members: Amtrol, Possible Modifications, 2015 Review obtain information on this matter by
Inc., West Warwick, Rhode Island; contacting the Commission’s TDD
AGENCY: United States International terminal at 202–205–1810. General
Arkema, Inc., King of Prussia,
Trade Commission. information concerning the Commission
Pennsylvania; The Chemours Company
FC LLC, Wilmington, Delaware; ACTION: Notice of institution of may also be obtained by accessing its
Honeywell International Inc., investigation and scheduling of public Web site (http://www.usitc.gov). Persons
Morristown, New Jersey; Hudson hearing. with mobility impairments who will
Technologies, Pearl River, New York; need special assistance in gaining access
SUMMARY: Following receipt of a request
Mexichem Fluor Inc., St. Gabriel, to the Commission should contact the
on December 30, 2015, from the United
Louisiana; Worthington Industries, Inc., Office of the Secretary at 202–205–2000.
States Trade Representative (USTR), the
Columbus, Ohio; and District Lodge 154 U.S. International Trade Commission Background
of the International Association of (Commission) instituted investigation
Machinists and Aerospace Workers filed In his letter, the USTR requested the
No. 332–556, Generalized System of advice and information described
a petition with the Commission and
Preferences: Possible Modifications, below.
Commerce, alleging that an industry in
2015 Review, for the purpose of (1) Advice concerning the probable
the United States is materially injured
providing advice and information economic effect of elimination of U.S.
by reason of LTFV imports of
relating to the possible designation of import duties on certain articles from all
hydrofluorocarbon blends and
additional articles, removal of articles, beneficiary developing countries under
components from China. Accordingly,
and waiver of competitive need the GSP program. In accordance with
effective July 2, 2015, the Commission,
limitations. sections 503(a)(1)(A), 503(e), and 131(a)
pursuant to section 733(a) of the Tariff
Act of 1930 (19 U.S.C. 1673b(a)), DATES: of the Trade Act of 1974, as amended
instituted antidumping duty February 1, 2016: Deadline for filing (‘‘the 1974 Act’’) (19 U.S.C.
investigation No. 731–TA–1279 requests to appear at the public hearing. 2463(a)(1)(A), 2463(e), and 2151(a)), and
(Preliminary). February 3, 2016: Deadline for filing pursuant to the authority of the
Notice of the institution of the pre-hearing briefs and statements. President delegated to the USTR by
Commission’s investigation and of a February 24, 2016: Public hearing. sections 4(c) and 8(c) and (d) of
public conference to be held in February 29, 2016: Deadline for filing Executive Order 11846 of March 31,
connection therewith was given by post-hearing briefs and statements. 1975, as amended, and pursuant to
asabaliauskas on DSK5VPTVN1PROD with NOTICES
posting copies of the notice in the Office February 29, 2016: Deadline for filing section 332(g) of the Tariff Act of 1930
of the Secretary, U.S. International all other written submissions. (19 U.S.C. 1332(g)), the USTR notified
Trade Commission, Washington, DC, April 28, 2016: Transmittal of the Commission that the articles
and by publishing the notice in the Commission report to the United States identified in Table A of the Annex to
Federal Register of July 2, 2015 (80 FR Trade Representative. the USTR request letter are being
38231). The conference was held in ADDRESSES: All Commission offices, considered for designation as eligible
Washington, DC, on July 16, 2015, and including the Commission’s hearing articles for purposes of the GSP
all persons who requested the rooms, are located in the United States program. The USTR requested that the
VerDate Sep<11>2014 17:50 Jan 15, 2016 Jkt 238001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\19JAN1.SGM 19JAN1](https://thefederalregister.org/doc/81_FR_2915/page/1.svg)
![Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices 2907
Summaries of Written Submissions DEPARTMENT OF JUSTICE The DEA has considered the factors in
The Commission intends to publish 21 U.S.C. 823, 952(a) and 958(a) and
summaries of the positions of interested Drug Enforcement Administration determined that the registration of
persons. Persons wishing to have a Lipomed, Inc. to import the basic
summary of their position included in [Docket No. DEA–392] classes of controlled substances is
the report should include a summary consistent with the public interest and
with their written submission. The Importer of Controlled Substances with United States obligations under
summary may not exceed 500 words, Registration: Lipomed, Inc. international treaties, conventions, or
should be in MSWord format or a format protocols in effect on May 1, 1971. The
ACTION: Notice of registration.
that can be easily converted to MSWord, DEA investigated the company’s
and should not include any confidential SUMMARY: Lipomed, Inc. applied to be maintenance of effective controls
business information. The summary will registered as an importer of certain basic against diversion by inspecting and
be published as provided if it meets classes of controlled substances. The testing the company’s physical security
these requirements and is germane to Drug Enforcement Administration systems, verifying the company’s
the subject matter of the investigation. (DEA) grants Lipomed, Inc. registration compliance with state and local laws,
The Commission will identify the name as an importer of those controlled and reviewing the company’s
of the organization furnishing the substances. background and history.
summary and will include a link to the
Commission’s Electronic Document SUPPLEMENTARY INFORMATION: By notice Therefore, pursuant to 21 U.S.C.
Information System (EDIS) where the dated June 25, 2015, and published in 952(a) and 958(a), and in accordance
full written submission can be found. the Federal Register on July 6, 2015, 80 with 21 CFR 1301.34, the above-named
FR 38468, Lipomed, Inc., One company is granted registration as an
By order of the Commission.
Broadway, Cambridge, Massachusetts importer of controlled substances:
Issued: January 12, 2016. 02142 applied to be registered as an
Lisa R. Barton, importer of certain basic classes of
Secretary to the Commission. controlled substances. No comments or
[FR Doc. 2016–00771 Filed 1–15–16; 8:45 am] objections were submitted for this
BILLING CODE 7020–02–P notice.
Controlled substance Schedule
Cathinone (1235) ................................................................................................................................................................................. I
Methcathinone (1237) ......................................................................................................................................................................... I
Mephedrone (4-Methyl-N-methylcathinone) (1248) ............................................................................................................................ I
N-Ethylamphetamine (1475) ............................................................................................................................................................... I
N,N-Dimethylamphetamine (1480) ...................................................................................................................................................... I
Fenethylline (1503) .............................................................................................................................................................................. I
Aminorex (1585) .................................................................................................................................................................................. I
4-Methylaminorex (cis isomer) (1590) ................................................................................................................................................ I
Gamma Hydroxybutyric Acid (2010) ................................................................................................................................................... I
Methaqualone (2565) .......................................................................................................................................................................... I
Mecloqualone (2572) ........................................................................................................................................................................... I
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) (6250) .......................................................................................................... I
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) (7008) ........................................................ I
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) (7019) .............................................................................................................................. I
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) (7081) .......................................................................................................... I
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104) ............................................................................. I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl) indole) (7118) ..................................................................................... I
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) (7122) ............................................................................................................. I
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) (7173) ............................................................................................................................... I
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole) (7200) ................................................................................................. I
AM–2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) (7201) ............................................................................................................. I
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) (7203) .............................................................................................................. I
Alpha-ethyltryptamine (7249) .............................................................................................................................................................. I
Ibogaine (7260) ................................................................................................................................................................................... I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297) ......................................................................... I
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298) ................................................... I
Lysergic acid diethylamide (7315) ...................................................................................................................................................... I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) (7348) ...................................................................................................... I
Marihuana (7360) ................................................................................................................................................................................ I
Tetrahydrocannabinols (7370) ............................................................................................................................................................ I
Parahexyl (7374) ................................................................................................................................................................................. I
Mescaline (7381) ................................................................................................................................................................................. I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) (7385) .................................................................................................... I
asabaliauskas on DSK5VPTVN1PROD with NOTICES
3,4,5-Trimethoxyamphetamine (7390) ................................................................................................................................................ I
4-Bromo-2,5-dimethoxyamphetamine (7391) ...................................................................................................................................... I
4-Bromo-2,5-dimethoxyphenethylamine (7392) .................................................................................................................................. I
4-Methyl-2,5-dimethoxyamphetamine (7395) ...................................................................................................................................... I
2,5-Dimethoxyamphetamine (7396) .................................................................................................................................................... I
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole (7398) ............................................................................................................... I
2,5-Dimethoxy-4-ethylamphetamine (7399) ........................................................................................................................................ I
3,4-Methylenedioxyamphetamine (7400) ............................................................................................................................................ I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) .......................................................................................................................... I
VerDate Sep<11>2014 17:50 Jan 15, 2016 Jkt 238001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\19JAN1.SGM 19JAN1](https://thefederalregister.org/doc/81_FR_2915/page/4.svg)
Document Created: 2016-01-16 01:12:46
Document Modified: 2016-01-16 01:12:46
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of institution of investigation and scheduling of public hearing. | |
| Dates | February 1, 2016: Deadline for filing requests to appear at the public hearing. | |
| Contact | Information specific to this investigation may be obtained from Mahnaz Khan, Project Leader, Office of Industries (202-205-2046 or [email protected]), Jessica Pugliese, Deputy Project Leader, Office of Industries (202-205-3064 or [email protected]), or Cynthia Foreso, Technical Advisor, Office of Industries (202-205-3348 or [email protected]). For information on the legal aspects of this investigation, contact William Gearhart of the Commission's Office of the General Counsel (202-205- 3091 or [email protected]). The media should contact Margaret O'Laughlin, Office of External Relations (202-205-1819 or mar[email protected]). Hearing-impaired individuals may obtain information on this matter by contacting the Commission's TDD terminal at 202-205-1810. General information concerning the Commission may also be obtained by accessing its Web site (http://www.usitc.gov). Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202-205-2000. | |
| FR Citation | 81 FR 2904 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR